Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

PAL vs AAPG: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

PAL Wins Head-to-Head Institutional Verdict (4–1 across 6 Pillars · 6–3 Matrix Metrics)

PAL Overall Winner 6-Pillar Tally: PAL 4 – 1 AAPG (1 Tie) Matrix Metrics: PAL 6 – 3 AAPG

As of Nov 16, 2026, Proficient Auto Logistics, Inc. (PAL) is the stronger overall head-to-head candidate over Ascentage Pharma Group International American Depository Shares (AAPG) in the Tradestie Institutional Equity Comparison Engine, winning 6–3 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). PAL carries a Unified Composite Score of 49.8/100 (HOLD) at $2.60 (10.2x Forward P/E, -4.3% operating margin), whereas AAPG carries 49.7/100 (HOLD) at $13.29 (9.4x Forward P/E, -219.5% operating margin).

  • Technical & Structure Timing Caution: PAL is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.3); meanwhile AAPG is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 36.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About PAL vs AAPG
PAL NASDAQ Head-to-Head Winner
Proficient Auto Logistics, Inc. Common Stock
Transportation Services
$2.60
-0.76% 1D
Market Cap $73.3M
TTM Revenue $457M
Forward P/E 10.2x
Beta / 30D Vol 1.19β · 105% Vol
Unified Composite Score
49.8 / 100 HOLD
Tech 44.0 Fund 61.0 Flow 50.0 Mom 64.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -23.0%), weak momentum, RSI 37
RSI-14: 37.3 · SMA20: $2.81 · SMA50: $3.46
AAPG NASDAQ
Ascentage Pharma Group International American Depository Shares
Pharmaceutical Preparations
$13.29
-9.1% 1D
Market Cap $1.4B
TTM Revenue $643M
Forward P/E 9.4x
Beta / 30D Vol 1.32β · 70% Vol
Unified Composite Score
49.7 / 100 HOLD
Tech 58.0 Fund 57.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -7.0%), weak momentum, RSI 36
RSI-14: 36.0 · SMA20: $14.94 · SMA50: $15.30

6-Pillar Scorecard Institutional Category Breakdown (PAL 4 – 1 AAPG)

Columns: Metric · PAL · AAPG
1. Valuation Multiples PAL
Forward P/E 10.2x 9.4x
Trailing P/E 3.4x 9.4x
PEG Ratio 0.23x N/M
EV / Revenue 0.2x 2.1x
2. Growth & Scale AAPG
Revenue Growth (YoY) +30.3% +29.3%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) $457M $643M
Market Cap $73.3M $1.4B
3. Profitability & Quality PAL
Gross Margin 16.4% 93.9%
Operating Margin -4.3% -219.5%
Net Profit Margin -10.6% -228.5%
Return on Equity (ROE) -15.6% -236.6%
4. Balance Sheet & Cash Flow PAL
Cash Generation (TTM) $19M EBITDA -$1.34B EBITDA
Cash Flow Margin 4.2% EBITDA Mgn N/A
Net Cash / Leverage $10.13 Book/Sh · -15.6% ROE $0.89 Book/Sh · -236.6% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 45.5% (<1st %ile) N/A (N/A)
Put/Call OI Skew N/A Thin ADR Chain
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat PAL
OpEx & R&D Intensity 20.7% of Rev ($95M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Integrated Freight & Logistics Operator Biotechnology Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: PAL (6) vs AAPG (3)
Institutional Metric PAL AAPG Criterion Row Edge
Market Capitalization
Scale
$73.3M $1.4B Larger Scale AAPG
Trailing P/E Ratio
Valuation
3.4x 9.4x Lower Multiple PAL
Forward P/E Ratio
Valuation
10.2x 9.4x Lower Multiple AAPG
Revenue Growth (YoY)
Growth
+30.3% +29.3% Higher Growth PAL
Operating Margin (TTM)
Profitability
-4.3% -219.5% Higher Margin PAL
Net Profit Margin
Profitability
-10.6% -228.5% Higher Margin PAL
Return on Equity (ROE)
Capital Efficiency
-15.6% -236.6% Higher ROE PAL
52-Week Range Position
Momentum
3% ($2–$11) 0% ($13–$34) Stronger Trend PAL
Beta / 30D Volatility
Risk Regime
1.19β · 105% Vol 1.32β · 70% Vol Lower Realized Risk AAPG
Unified Institutional Score
Composite Signal
49.8 / 100 (HOLD) 49.7 / 100 (HOLD) Higher Composite Tie
Trailing 12M Revenue (USD)
Operating Scale
$457M $643M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
16.4% 93.9% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.23x PEG · 0.2x EV/Rev N/M PEG · 2.1x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$19M EBITDA ($10.13 Book/Sh · -15.6% ROE) -$1.34B EBITDA ($0.89 Book/Sh · -236.6% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon AAPG +4.84 pp
PAL: -18.37% · AAPG: -13.53%
3M Horizon AAPG +26.77 pp
PAL: -53.74% · AAPG: -26.97%
6M Horizon AAPG +16.62 pp
PAL: -50.76% · AAPG: -34.14%
1Y Horizon AAPG +6.14 pp
PAL: -66.67% · AAPG: -60.53%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PAL vs AAPG. Trailing 12-month operating profitability (PAL -4.3% vs AAPG -219.5%) and valuation multiples (PAL 10.2x vs AAPG 9.4x Forward P/E) are benchmarked directly in Pillar 4 below.

PAL ADR TTM Benchmark FX-Normalized USD
TTM Revenue$457M
Gross Margin16.4%
Op. Margin-4.3%
ROE / Fwd P/E-15.6% · 10.2x
AAPG ADR TTM Benchmark FX-Normalized USD
TTM Revenue$643M
Gross Margin93.9%
Op. Margin-219.5%
ROE / Fwd P/E-236.6% · 9.4x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
PAL UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 45.5%
IV Percentile <1st %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact PAL Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
AAPG UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew Thin ADR Chain
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact AAPG Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
PAL Moat Profile Cyclical / Execution-Driven Positioning
Integrated Freight & Logistics Operator
Competes within the Integrated Freight & Logistics value chain with $73.3M market capitalization and -4.3% operating margin.
OpEx & R&D Reinvestment 20.7% of Rev ($95M)
90D Engineering Disclosures 0 Published
AAPG Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $1.4B market capitalization and -219.5% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ PAL vs AAPG Key Questions & Quantitative Answers

As of Nov 16, 2026, Proficient Auto Logistics, Inc. (PAL) is the stronger overall head-to-head candidate over Ascentage Pharma Group International American Depository Shares (AAPG) in the Tradestie Institutional Equity Comparison Engine, winning 6–3 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). PAL carries a Unified Composite Score of 49.8/100 (HOLD) at $2.60 (10.2x Forward P/E, -4.3% operating margin), whereas AAPG carries 49.7/100 (HOLD) at $13.29 (9.4x Forward P/E, -219.5% operating margin). Technical & Structure Timing Caution: PAL is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.3); meanwhile AAPG is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 36.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

AAPG leads the Growth & Scale pillar: PAL posts +30.3% YoY revenue growth and +0.0% YoY earnings growth on $457M TTM revenue (16.4% gross margin, -4.3% operating margin), compared with AAPG at +29.3% YoY revenue growth and +0.0% YoY earnings growth on $643M TTM revenue (93.9% gross margin, -219.5% operating margin). On trailing 12-month operating scale, PAL generates $457M in USD-normalized revenue versus $643M for AAPG. In operating R&D and SG&A reinvestment, PAL deploys 20.7% of Rev ($95M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for AAPG.

PAL screens cheaper on headline valuation multiples. PAL trades at 10.2x Forward P/E, 3.4x Trailing P/E, 0.23x PEG, and 0.2x EV/Revenue (4.2% EBITDA margin), whereas AAPG trades at 9.4x Forward P/E, 9.4x Trailing P/E, N/M PEG, and 2.1x EV/Revenue (unreported EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against PAL (-15.6% ROE) versus AAPG (-236.6% ROE) capital efficiency.

In options market volatility and institutional positioning, PAL carries 45.5% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.19β · 105% Vol realized risk). By comparison, AAPG carries N/A implied volatility (N/A, Unclassified), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.32β · 70% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Proficient Auto Logistics, Inc. Common Stock (PAL) Research Suite

Ascentage Pharma Group International American Depository Shares (AAPG) Research Suite

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.